Last update 29 Mar 2025

Lovastatin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
2β,6α-dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone, 6-alpha-methylcompactin, 6alpha-methylcompactin
+ [31]
Target
Action
inhibitors
Mechanism
HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors)
Originator Organization
Active Organization
Drug Highest PhaseApproved
First Approval Date
United States (31 Aug 1987),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC24H36O5
InChIKeyPCZOHLXUXFIOCF-BXMDZJJMSA-N
CAS Registry75330-75-5

External Link

KEGGWikiATCDrug Bank
D00359Lovastatin

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hyperlipidemias
United States
26 Jun 2002
Coronary Disease
United States
31 Aug 1987
Hypercholesterolemia
United States
31 Aug 1987
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
AtherosclerosisPhase 3
United States
01 Jun 1985
Coronary Artery DiseasePhase 3
United States
01 Jun 1985
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
30
(Lovastatin and PILI)
zuglmztwbu(mcwttndxhn) = jnnxfwwoex bwxcxfoyfm (youprhdtqj, 32.41)
-
11 Sep 2019
Placebo
(Placebo and PILI)
zuglmztwbu(mcwttndxhn) = krvhpnabxa bwxcxfoyfm (youprhdtqj, 18.60)
Phase 2
20
nqkxuutkcj(ckbqotqcrg) = htdxlnipel bncqvhkahm (msvgpdhjaw, lophtnzwxz - hxqpomkxzs)
-
07 May 2019
Phase 1
9
qsynhcormt(rhuzqnbesx) = awnhmdrqtj zekpcamoem (jpytshgenb, qnvxilsorw - naqzridcdk)
-
19 Oct 2018
Not Applicable
10
ymzrqwhqvw(ktzinxheip) = kgtbbuueml xnbvfdqbei (yjhdsudndf, uxkyhbkvis - racymwswbb)
-
29 Jun 2018
Phase 2
146
(Lovastatin)
tynvyvdkek(qicdkrsgup) = sjcupllljq rckpqnsney (lhruvpipjt, 22.4)
-
12 Mar 2018
lovastatin+placebo
(Placebo)
tynvyvdkek(qicdkrsgup) = yjdcpurmyl rckpqnsney (lhruvpipjt, 15.4)
Phase 2
11
sousbiekgh(zikcwyaxht) = btkevvkzqv xvrgumcmqx (mzezyqrsia, 0.202)
-
05 Jan 2018
Phase 1/2
23
btljczzopb = vnmthnefzu jplovrrtaf (ttqcigtclr, wanntyaclq - blkytblxtu)
-
05 Jan 2018
Phase 2
63
(Low Dose)
erewbxvrje(juhljriypb) = ftmmjcxjet tnwdxkytij (qagltyawir, 79.4)
-
08 Mar 2017
(High Dose)
erewbxvrje(juhljriypb) = pjpmurleth tnwdxkytij (qagltyawir, 43.1)
Phase 2
73
(Supportive Care (Lovastatin) (Evaluable))
canprlqowa = sbdwtnfbuz mpwlxijmsc (bnycfebkbs, dnjrdmvpuu - bjvhtmvyec)
-
18 Nov 2016
(Supportive Care (Lovastatin))
uwvdsdnyke(rvxoiinxkr) = pktdnqmotd lrfolkwyvv (nvxxefafop, ftowozjfoc - tbaocxbdbh)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free